Success Of New Screening And Shot Gives Hope To Patients Suffering From Cancer

Health chiefs revealed that new technology may soon eliminate cervical cancer. The new technology involves the use of an enhanced screening method.

In the past, screening samples are examined with those showing likely cell changes subjected to testing for the human papillomavirus viral infection. This infection causes some types of cancer.

Today, the National Health Service has released new technology that involves testing the patients first for HPV infection. Only those that show signs of the virus subjected to examination for abnormal cells. This means any sign of infection may now be recognized and treated early on before it transforms into cancer.

At least 25% of the 2,500 cervical cancer cases in England annually could now be stopped by the new examination method. According to the national clinical director for cancer, Professor Peter Johnson, screening is among the best ways of having protection against cervical cancer. He also expressed his belief that this new testing method will save lives.

To keep people safe, it is very important for all eligible people to participate in screening appointments, added Professor Johnson. When used in combination with the HPV vaccine for both girls and boys, Johnson hopes it will pave the way for the elimination of cervical cancer in England.

For Public Health Minister Jo Churchill, she believes with the enhanced screening services used in combination with the HPV vaccine, cases of cervical cancer will be reduced. She also is very happy at the prospect that cervical cancer may be eliminated for good. Public Health England’s Anne Mackie agrees at this notion and added that the breakthrough process is a momentous achievement.

Health chiefs in England, however, strongly advised women to continue attending their screenings. NHS data shows that between 2018 and 2019, nearly one million women did not attend their cervical screening appointments. The same data shows that invitations were sent out to 4.41 million women to attend screening appointments, but as it turned out, many chose to be absent.

For the first time in half-decade, there is an increase in coverage among women considered eligible and who were 25 to 64 years old. Approximately 3.43 million were examined for cancer.